TG Therapeutics, Inc. Announces Clinical Data Presentations at Upcoming Conferences

[GlobeNewswire] – NEW YORK — TG Therapeutics, Inc. , today announced upcoming presentations of clinical data for TG-1101, the Company’s next generation, glycoengineered anti-CD20 monoclonal antibody and for TGR-1202, the … more

View todays social media effects on TGTX

View the latest stocks trending across Twitter. Click to view dashboard

See who TG is hiring next, click here to view